On track to define optimal dosing interval and advance manufacturing scale up of REYOBIQ for pivotal trial readiness in late ...
Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals ...
Zacks Investment Research on MSN
OTLK stock crashes 67% in a week: Here's what you need to know
Shares of Outlook Therapeutics OTLK have tumbled 66.5% in a week. The massive crash was observed after the FDA issued a third ...
According to MarketsandMarketstm, the Pharmaceutical Microfiltration Market is projected to grow from about USD 6.13 billion in 2025 to USD 9.94 billion by 2030, at a CAGR of ...
Solar physicists say they have found a key source of intense gamma rays unleashed when Earth's nearest star produces its most ...
Johnson & Johnson today announced new longer follow-up results from the investigational Phase 1b/2 OrigAMI-1 study evaluating amivantamab-vmjw, a bispecific antibody targeting epidermal growth factor ...
Get PowerPoint guidance for 2026, covering the notes pane and master slide so your deck stays consistent and delivery feels smooth.
Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. Natalya Yashina is a CPA, DASM with over 12 years of experience in ...
Wall Street awaits Fed Chair Powell and counterparts at ECB forum Mortgage demand rises for a 3rd straight week 10-year Treasury yield down 1.9 bps to 3.745% The artificial intelligence trade had a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback